Haem is used as a versatile receptor for redox active molecules; most notably NO (nitric oxide) and oxygen. Three haemcontaining proteins, myoglobin, haemoglobin and cytochrome c oxidase, are now known to bind NO, and in all these cases competition with oxygen plays an important role in the biological outcome. NO also binds to the haem group of sGC (soluble guanylate cyclase) and initiates signal transduction through the formation of cGMP in a process that is oxygen-independent. From biochemical studies, it has been shown that sGC is substantially more sensitive to NO than is cytochrome c oxidase, but a direct comparison in a cellular setting under various oxygen levels has not been reported previously. In this issue of the Biochemical Journal, Cadenas and co-workers reveal how oxygen can act as the master regulator of the relative sensitivity of the cytochrome c oxidase and sGC signalling pathways to NO. These findings have important implications for our understanding of the interplay between NO and oxygen in both physiology and the pathology of diseases associated with hypoxia.Key words: cytochrome c oxidase, haem (heme), mitochondria, nitric oxide, redox signalling.Nitric oxide (NO) is an unusual signalling molecule since its biological responses are primarily governed by its chemical reactivity [1]. In fact, the first signalling function of NO was revealed with the discovery that NO serves as a ligand for the haem group in sGC (soluble guanylate cyclase), resulting in increased cGMP production and activation of downstream signalling cascades. However, the story became more complex with the recognition that NO serves as a ligand for other haem proteins such as COX (cytochrome c oxidase) in the mitochondria and haemoglobin in the red blood cell [2,3]. The fact that NO interacts with the haem groups that normally bind oxygen essentially expanded the role of NO in cell signalling from a simple haem ligand to a regulatory modulator of oxygen-sensitive processes [4][5][6].Since both COX and sGC frequently co-exist within the same cell, the relative sensitivity of the two pathways to NO should determine the ultimate biological effect. It has been shown that activation of sGC occurs at much lower concentrations of NO than inhibition of COX, but these studies have not addressed the sensitivity of these pathways using endogenous NO formation; nor have they investigated the influence of oxygen on this relative sensitivity in a cellular setting [7]. Using an elegant experimental model that allows the controlled formation of NO from iNOS (inducible NO synthase) in cells that contain both COX and sGC, the authors have compared the response of these two signalling pathways with the concentration of NO measured extracellularly. Several endpoints were selected to assess the activity of sGC and COX. These include production of cGMP and phosphorylation of VASP (vasodilator-stimulated phosphoprotein) for the sGC pathway, and oxygen consumption and AMPK (AMP-activated protein kinase) phosphorylation for the COX pathway. The acti...